Canaan XI L.P. - May 26, 2021 Form 3 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
10%+ Owner
Signature
Canaan XI L.P., By: Canaan Partners XI LLC, its general partner, By: /s/ Nancy Levenson, Attorney-in-Fact
Stock symbol
DAWN
Transactions as of
May 26, 2021
Transactions value $
$0
Form type
3
Date filed
5/26/2021, 08:45 PM
Next filing
Jun 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DAWN Common Stock 3.25M May 26, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DAWN Series A Preferred Stock May 26, 2021 Common Stock 7.33M Direct F1, F2
holding DAWN Series B Preferred Stock May 26, 2021 Common Stock 148K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are held directly by Canaan XI L.P. (the "Canaan Fund"). The sole general partner of the Canaan Fund is Canaan Partners XI LLC ("Canaan XI", and together with the Canaan Fund, the "Canaan Entities"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Investment and voting decisions with respect to the shares held by the Canaan Fund are made by the managers of Canaan XI, collectively. Canaan XI disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.
F2 Each share of Class A Preferred Stock is automatically convertible into one share of Common Stock at the close of the Issuer's initial public offering and has no expiration date.
F3 Each share of Class B Preferred Stock is automatically convertible into one share of Common Stock at the close of the Issuer's initial public offering and has no expiration date.

Remarks:

Exhibit 24 - Power of Attorney filed herewith